Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort

Barry R. Palmer, Martin D. Jarvis, Anna P. Pilbrow, Katrina L. Ellis, Chris M. Frampton, Lorraine Skelton, Tim G. Yandle, Rob N. Doughty, Gillian A. Whalley, Chris J. Ellis, Richard W. Troughton, A. Mark Richards, Vicky A. Cameron

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)


Background: Polymorphisms of the angiotensin-converting enzyme 2 (ACE2) gene, which is located on the X chromosome, have been associated with hypertension and left ventricular hypertrophy in previous studies. We tested the hypothesis that the rare allele of an ACE2 gene polymorphism was associated with risk factors for and adverse outcome after acute coronary syndrome (ACS) events. Methods: Patients (n = 1,042) were recruited after admission for an ACS event and were genotyped for the A1075G polymorphism of the angiotensin-converting enzyme 2 gene. This genetic marker was tested for association with baseline measurements, echocardiographic measurements, and clinical outcome, over a median 2.19 years follow-up. As the ACE2 gene is X-linked, analyses were performed separately for males and females. Patients were predominantly of European ethnicity (90.1%). Results: The A1075 allele was significantly associated with covariate-adjusted mortality in male patients (hazard ratio 1.95, 95% CI 1.10-3.46, P = .047) but not unadjusted (hazard ratio 1.14, 95% CI 0.736-1.76, P = .56). The G1075 (P < .035) allele was more frequent in patients of Maori compared to European ancestry. E/E′, an echocardiographic index of left ventricular diastolic function and filling pressure, was higher in males in the A1075 group (G allele group 10.5 [95% CI 10.0-11.0], A allele group 11.4 [95% CI 10.8-12.1], P = .024). A1075 genotype was significantly associated with male survival in the absence of (mortality: A 12.8%, n = 39; G 29.2%, n = 48; P = .037) but not in the presence of β-blocker treatment (mortality: A 13.5% n = 273; G 8.2% n = 304, P = nonsignificant). Conclusions: The A1075 allele was associated with covariate-adjusted mortality in male patients.

Original languageEnglish
Pages (from-to)752-758
Number of pages7
JournalAmerican Heart Journal
Issue number4
Early online date15 Aug 2008
Publication statusPublished - Oct 2008
Externally publishedYes


Dive into the research topics of 'Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort'. Together they form a unique fingerprint.

Cite this